{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:08:06Z","timestamp":1787987286199,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ejogrb.2003.09.030","type":"journal-article","created":{"date-parts":[[2004,1,22]],"date-time":"2004-01-22T05:19:43Z","timestamp":1074748783000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception"],"prefix":"10.1016","volume":"112","author":[{"given":"Adolf E.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2003.09.030_BIB1","unstructured":"James VHT, Goodall A. Androgen production in women. In: Jeffcoate SL, editor. Androgen- and antiandrogen therapy. Lancaster: Wiley, 1982. p. 23\u201340."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: another progestogen with antimineralocorticoid and antiandrogenic activity","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB3","doi-asserted-by":"crossref","unstructured":"Schindler AE. Antiandrogen estrogens therapy for signs of androgenisation. New developments in biosciences, vol. 3. Berlin: Walther de Gruyter, 1987.","DOI":"10.1515\/9783110866902-003"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB4","unstructured":"Loch EG, Schramm G. Chlormadinonacetat bei Androgenisierungserscheinungen. Stuttgart: Schattauer, 1995."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB5","first-page":"29","article-title":"Pharmacology of nortestosterone derivatives","volume":"VI","author":"Golbs","year":"2001","journal-title":"Menopause Rev."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB6","first-page":"527","article-title":"Neue Gestagene- ihre Vor- und Nachteile","volume":"58","author":"Kuhl","year":"2001","journal-title":"Therap. Rundschau"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB7","first-page":"392","article-title":"Long-term therapy of signs of androgenisation with low-dosed antiandrogen\u2013estrogen combination","volume":"27","author":"Aydinlik","year":"1990","journal-title":"Clin. Trial J."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/09546639809161376","article-title":"The efficacy of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type","volume":"9","author":"Gollwick","year":"1998","journal-title":"J. Dermatol. Treatment"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/humrep\/16.1.36","article-title":"Efficacy of the combination ethinylestradiol and cyproterone acetate in endocrine, clinical and ultrasonic profile in polycystic ovary syndrome","volume":"16","author":"Falsetti","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB10","doi-asserted-by":"crossref","unstructured":"Ashton RE, Miller JA, Wojnarowska FT, Dowd PM, O\u2019Brian TJ, Griffiths WAD, Jacobs HS. Antiandrogen treatment in women with acne: a controlled trial. In: Schindler AE, editor. Antiandrogen\u2013estrogen therapy for signs of androgenization. New developments in biosciences, vol. 3. Berlin: Walther de Gruyter, 1987. p. 117\u201330.","DOI":"10.1515\/9783110866902-013"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1083-3188(97)70072-X","article-title":"Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents","volume":"10","author":"Dramusic","year":"1997","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-200222040-00002","article-title":"Contraceptive efficacy and tolerability of chlormadinone acetate 2mg\/ethinylestradiol 0.03mg (Belara\u00ae). Results of a marketing surveillance study","volume":"22","author":"Schramm","year":"2002","journal-title":"Clin. Drug Invest."},{"issue":"Suppl. C","key":"10.1016\/j.ejogrb.2003.09.030_BIB13","first-page":"97","article-title":"Effects of the dieonogest-containing oral contraceptive Valette\u00ae on skin and hair. Results of a post-marketing surveillance study","volume":"35","author":"Zimmermann","year":"1999","journal-title":"Drugs Today"},{"issue":"Suppl. 3","key":"10.1016\/j.ejogrb.2003.09.030_BIB14","first-page":"34","article-title":"The acceptability of a novel oral contraceptive containing drospirenone and its effects on well-being","volume":"5","author":"Bokisch","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB15","unstructured":"Drife JO. The benefits and risks of oral contraceptives today. 2nd ed. Carnforth (UK): Parthenon Publishing, 1996. p. 23."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02133945","article-title":"Ultrasound study of ovarian and uterine morphology in women with PCOS before, during and after treatment with CPA and EE","volume":"237","author":"Venturoli","year":"1987","journal-title":"Arch. Gynecol."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00670846","article-title":"Therapy of androgenic symtomatology with cyproterone acetate and ethinylestradiol","volume":"225","author":"Schindler","year":"1978","journal-title":"Arch. Gyn\u00e4k."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB18","unstructured":"Zaradnik HP, Moore C. Clinical experience with an oral contraceptive containing ethinylestradiol dienogest. In: Elstein M, editor. Extragenital effects of oral contraceptives. Lancaster: Parthenon, 1997. p. 53\u201361."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1742-1241.2000.tb11855.x","article-title":"The effects of Valette\u00ae on skin and hair: a postmarketing surveillance study","volume":"54","author":"Zimmermann","year":"2000","journal-title":"Int. J. Clin. Pract."},{"issue":"Suppl. 3","key":"10.1016\/j.ejogrb.2003.09.030_BIB20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB21","unstructured":"Moltz L. Differenzierter Einsatz von Cyproteronazetat bei verschiedenen androgenbedingten Krankheitsbildern der Frau. In: Breckwoldt M, editor. Diagnostik und Therapie von Androgenisierungserscheinungen bei der Frau. Berlin: Diesbach, 1992. p. 154\u201361."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB22","unstructured":"Godsland IF, Stevenson JC. Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implication for heart disease and diabetes risk. Br J Clin Pract 1998;86, Suppl:1\u20135."},{"key":"10.1016\/j.ejogrb.2003.09.030_BIB23","unstructured":"Rosano GMC, Vitale C, Silvestre A, Fini M. Metabolic and vascular effect of progestins in postmenopausal women. Implication for cardioprotection. Maturitas, in press."},{"issue":"4","key":"10.1016\/j.ejogrb.2003.09.030_BIB24","first-page":"2","article-title":"The effect of two combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"Van Vloten","year":"2002","journal-title":"Cutis"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211503004949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211503004949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:10:09Z","timestamp":1759554609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211503004949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0301211503004949"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2003.09.030","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2003.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}